T Cell News and Research

Latest T Cell News and Research

SYS6006 investigational COVID-19 mRNA vaccine shows promise as fourth dose booster

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide.

4 Jul 2023

Immune inflammatory reaction to COVID-19 may not be the underlying cause of long Covid

Long Covid, which affects nearly two-million people in the UK, is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds.

4 Jul 2023

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

Researchers used antibody testing to predict the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

3 Jul 2023

New COVID-19 mRNA vaccine is safe and highly immunogenic as a heterologous booster: Study

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in more than 600 million confirmed cases and 6.5 million deaths worldwide.

3 Jul 2023

How does space affect the immune system of astronauts?

Research explores the effects of microgravity and radiation on the immune system in space conditions. It emphasizes the need to understand these effects for future long-duration space missions and highlights knowledge gaps for further investigation.

2 Jul 2023

Advances in influenza research

This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.

From Sino Biological Inc. 30 Jun 2023

Experimental antibody treatment shows promise for preventing bone marrow transplant complication

An experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease (GVHD) in the intestines, without causing broad immune suppression, in a preclinical study led by researchers from Penn Medicine and Dana-Farber/Boston Children's Cancer and Blood Disorders Center and published today in Science Translational Medicine.

28 Jun 2023

mRNA rabies vaccine induces durable immune response in macaques

Novel mRNA vaccine for rabies shows enhanced immune response with higher antibody levels and improved cross-neutralization, indicating potential for a broadly protective vaccine against related lyssavirus strains.

26 Jun 2023

Novel biomaterials approach reveals how mechanical forces shape T cell fate

The successful campaign of adoptive T cell therapies, a type of immunotherapy in which immune T cells are collected from a patient, enhanced outside of the body, and reinfused back into the same patient, especially against blood cancers is well under way.

26 Jun 2023

New project aims to improve the efficacy and safety of CAR T therapies for solid tumors

Partners in the international consortium CAR T-REX announce the awarding of a highly competitive EIC Pathfinder Open grant, following the positive evaluation of their project entitled 'CAR T Cells Rewired to Prevent EXhaustion in the Tumour Microenvironment'.

23 Jun 2023

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Cartesian Therapeutics, a clinical-stage biotechnology company pioneering cell therapies for autoimmune diseases, announced today the publication of a landmark paper in The Lancet Neurology.

22 Jun 2023

Battle against RSV: Computational design paves way for new polyvalent vaccine

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes computational methods and immunoinformatics tools to predict potential vaccine candidates and their interactions with Toll-like receptors (TLRs).

19 Jun 2023

Herbal extracts for mental health: Are they safe for pregnant women?

Researchers evaluate the T-cell modulating effects of St. John’s wort, valerian, hops, lavender, and California poppy.

18 Jun 2023

A new weapon against COVID: RBD-62 protein shows promising results in preventing severe disease

Researchers used aerosolized receptor binding domain (RBD)-62 with 1,000-fold enhanced binding affinity.

15 Jun 2023

Unlocking the secret to lifelong health: the power of optimal immune resilience

Researchers assessed immune resilience (IR) metrics in individuals across diverse infectious and non-infectious models.

15 Jun 2023

New base-edited T-cells proven effective to treat lymphoblastic leukemia

Three young patients with relapsed T-cell leukemia have now been treated with base-edited T-cells, as part of a 'bench-to-bedside' collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).

15 Jun 2023

CrossDome tool helps predict the potential risks of T-cell immunotherapy

Researchers at the University of Houston are working to make T-cell immunotherapy safer, developing a tool called CrossDome, which uses a combination of genetic and biochemical information to predict if T-cell immunotherapies might mistakenly attack healthy cells.

14 Jun 2023

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

Previous
1
...
8
9
10
11
12
13
14
...
2896
Next

T Cell News and Research

Latest T Cell News and Research

SYS6006 investigational COVID-19 mRNA vaccine shows promise as fourth dose booster

Immune inflammatory reaction to COVID-19 may not be the underlying cause of long Covid

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

New COVID-19 mRNA vaccine is safe and highly immunogenic as a heterologous booster: Study

How does space affect the immune system of astronauts?

Advances in influenza research

Experimental antibody treatment shows promise for preventing bone marrow transplant complication

mRNA rabies vaccine induces durable immune response in macaques

Novel biomaterials approach reveals how mechanical forces shape T cell fate

New project aims to improve the efficacy and safety of CAR T therapies for solid tumors

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Battle against RSV: Computational design paves way for new polyvalent vaccine

Herbal extracts for mental health: Are they safe for pregnant women?

A new weapon against COVID: RBD-62 protein shows promising results in preventing severe disease

Unlocking the secret to lifelong health: the power of optimal immune resilience

New base-edited T-cells proven effective to treat lymphoblastic leukemia

CrossDome tool helps predict the potential risks of T-cell immunotherapy

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

Study provides a new and promising strategy for future cancer immunotherapies

Study raises new hopes for blood cancer patients with an incomplete response to CAR T cell therapy

Immunology eBook

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Newsletters you may be interested in